1. Brentuximab vedotin: A retrospective multicenter analysis of its indication, safety and efficacy in Argentina. (June 2017) Authors: Negri Aranguren, M.F.; Shanley, C.; Cranco, S.; Otero, V.; Fiad, L.; Fernandez, I.; Miodosky, M.; Kusminsky, G.; Corso, A.; Bistmans, A.; Huber, M.; Marull, M.; Jarchum, S.; Guanchiale, L.; Marquez, M.; Beligoy, L.; Cerutti, I.; Navieckas, A.; Tamashiro, M.; Pujol, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 320 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAFETY AND EFFICACY ANALYSIS OF ELDERLY PATIENTS TREATED WITHIN THE GATLA HL‐05 CLINICAL TRIAL: PET ADAPTED THERAPY AFTER 3 CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA. (June 2017) Authors: Ciliberti, E.; Fernandez, I.; Kurgansky, N.; Prates, V.; Zoppegno, L.; Negri, P.; Milone, G.; Cerutti, I.; Zabaljauregui, S.; Mariano, R.; Fernandez Grecco, H.; Saba, S.; Sackmann, F.; Castano, V.; Remaggi, G.; Cabrejo, M.; Rudoy, S.; Roveri, E.; Cabane, V.; Gumpel, C. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗